Benefits of insulin aspart vs phosphate-buffered human regular insulin in persons with type 1 Diabetes treated by means of an insulin pump.

Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia

Volumn 148, Issue 1, 2004, Pages 27-32

  Chlup, Rudolf ^a   Zapletalová, Jana ^a   Seckar, Pavel ^a   Chlupová, Ludmila ^a   Táncosová, Svatava ^a   Reznícková, Martina ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN ASPART; INSULIN, ASP(B28)-; LIPOPROTEIN;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; LIPOPROTEINS; MALE;

EID: 33646917209     PISSN: 12138118     EISSN: None     Source Type: Journal    
DOI: 10.5507/bp.2004.004     Document Type: Article

References (0)